Health

Source link : https://newshealth.biz/health-news/tile-based-radiation-tops-standard-for-resected-brain-metastases/ CHICAGO — Radioactive tiles implanted immediately after the surgical resection of a newly diagnosed brain metastasis improved local control over standard stereotactic radiotherapy (SRT) given weeks later, findings of a phase III trial showed. Median time to recurrence at the surgical bed was not reached with the Cesium-131 tiles (GammaTile), as compared with 17.4 months […] […] More

Source link : https://newshealth.biz/health-news/millions-of-breast-cancer-patients-could-safely-avoid-chemotherapy-study-suggests/ A new DNA test could help screen whether patients require the treatment or not, according to a new international trial. Source link : https://www.bbc.com/news/articles/c2325j0xk1vo?at_medium=RSS&at_campaign=rss Author : Publish date : 2026-05-30 08:46:00 Copyright for syndicated content belongs to the linked Source. The post Millions of breast cancer patients could safely avoid chemotherapy, study suggests first appeared on […] More

Source link : https://newshealth.biz/health-news/trump-in-excellent-health-after-annual-checkup-doctor-says/ In a memo released by the White House on Friday, Capt Sean Barbabella said Trump, who turns 80 next month, has “strong cardiac, pulmonary, neurological and overall physical function” and is “fully fit to carry out all duties of the Commander-in-Chief and Head of State”. Source link : https://www.bbc.com/news/articles/cx21v0ezv14o?at_medium=RSS&at_campaign=rss Author : Publish date : 2026-05-30 […] […] More

Source link : https://newshealth.biz/health-news/abolishing-patient-watchdog-leaves-nhs-marking-own-homework-councils-warn/ The plans are part of a government bill to modernise the NHS in England, which is currently going through parliament. Source link : https://www.bbc.com/news/articles/cn8pn2jplg9o?at_medium=RSS&at_campaign=rss Author : Publish date : 2026-05-30 00:08:00 Copyright for syndicated content belongs to the linked Source. The post Abolishing patient watchdog leaves NHS ‘marking own homework’, councils warn first appeared on News […] More

Source link : https://newshealth.biz/health-news/pcsk9-inhibitors-linked-to-better-survival-in-some-cancer-patients-on-immunotherapy/ Strong preclinical evidence suggested PCSK9 inhibitors may overcome immunotherapy resistance by preventing tumor cells from evading the immune system. In patients with lung cancer, melanoma, or kidney cancer, use of PCSK9 inhibitors, in addition to immunotherapy, was associated with better survival in this matched-cohort study. The survival benefit was independent of cardiovascular outcomes, suggesting an […] […] More

Source link : https://newshealth.biz/health-news/enhanced-mri-tops-ultrasound-in-catching-early-liver-cancer/ Enhanced, abbreviated MRI (AMRI) outperformed ultrasonography (US) as a screen for early liver cancer in high-risk patients with cirrhosis, according to a single-center, randomized clinical trial. Overall, AMRI yielded significantly more early-to-advanced stage cancer among 759 patients: the per-patient detection rate in Barcelona-Clinic Liver Cancer (BCLC) stage 0, A, B, or C hepatocellular carcinoma (HCC) […] […] More

Source link : https://newshealth.biz/health-news/cardiac-amyloidosis-diagnosis-gets-a-more-extensive-ai-model/ Researchers sought to show the incremental value of adding clinical and laboratory features to a transthoracic echocardiography-only AI model for cardiac amyloidosis (CA) diagnosis. The new model, dubbed AI-ECM, showed improved model performance in an internal validation study based on registry data. The ultimate goal is to improve early CA detection so patients can receive […] […] More

Source link : https://newshealth.biz/health-news/targeted-lung-cancer-drug-aces-confirmatory-trial-in-frontline-setting/ CHICAGO — An oral targeted drug reduced the risk of disease progression or death by 35% compared with chemotherapy when given as first-line treatment for non-small cell lung cancer (NSCLC) patients with EGFR exon 20 insertions, a randomized trial showed. In patients with nonsquamous NSCLC, median progression-free survival (PFS) reached 10.3 months with sunvozertinib (Zegfrovy) […] […] More

Source link : https://newshealth.biz/health-news/bispecific-antibody-boosts-survival-in-relapsed-refractory-multiple-myeloma/ CHICAGO — Teclistamab (Tecvayli) monotherapy significantly improved survival compared with standard therapies in patients with multiple myeloma who had received up to three previous lines of therapy, the phase III MajesTEC-9 trial showed. The estimated 18-month progression-free survival (PFS) rate was 69.8% with teclistamab compared with 26.9% with pomalidomide (Pomalyst), bortezomib (Velcade), and dexamethasone (PVd) […] […] More

Source link : https://newshealth.biz/health-news/no-difference-in-complications-for-chiari-i-surgical-approaches-in-kids-study-shows/ For kids with Chiari type I malformation and syringomyelia, there was no significant difference in surgical complications whether they had decompression with or without duraplasty, a cluster-randomized controlled trial showed. The percentage of participants with complications within 6 months of surgery was 14% with posterior fossa decompression with duraplasty (PFD-D) and 6% with PFD alone. […] […] More

Source link : https://newshealth.biz/health-news/what-did-fda-vaccine-advisors-decide-this-week/ The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted daily, but keeping up can be a challenge. As an aid for our readers, and for a little amusement, here is a 10-question quiz based on the news of the […] […] More

Source link : https://newshealth.biz/health-news/guselkumab-adds-psa-structural-damage-inhibition-to-label/ Guselkumab is the only IL-23 inhibitor that has been proven to help stop further structural damage in patients with active psoriatic arthritis. Medscape Medical News Source link : https://www.medscape.com/viewarticle/guselkumab-adds-psoriatic-arthritis-structural-damage-2026a1000i12?src=rss Author : Publish date : 2026-05-29 17:39:00 Copyright for syndicated content belongs to the linked Source. The post Guselkumab Adds PsA Structural Damage Inhibition to Label first […] More